Crossed from claiming to demonstrating: management marks its own before/after line with repeated, recent proof
The model's full reasoning — Q4 2023 call → NOWe need answer only YES or NO based on transcript. Need evaluate if management conveys recently crossed from claiming to demonstrating something, repeated recent events, management draws before/after contrast, payoff ahead. Look for examples. Vyleesi growth: six consecutive quarters double-digit growth, net product revenue exceeds operating expenses. Management says "we make some money." But is that crossing from claiming to demonstrating? They had prior quarters too. "With six consecutive quarters of double-digit growth... I think we are doing that." Objective re-license. Not exactly capability crossing. Another: PL9643 dry eye fully enrolled, data expected by year-end. Not demonstrated. PL8177 etc. Maybe "Vyleesi quarterly net product revenue continues to exceed Vyleesi quarterly operating expenses, i.e., we make some money." That's a capability? Previously maybe promised? Not really. Need question asks: "does management convey that the company has RECENTLY CROSSED FROM CLAIMING SOMETHING TO DEMONSTRATING IT — that a capability, offering, or way of doing business which until recently existed mainly as a promise, plan, or early attempt for THIS company is now something the company has actually done, and done MORE THAN ONCE, in the recent period — with management itself drawing the before-versus-now contrast?" Search for management drawing before/after. Steve Wills: "We have six consecutive quarters of double-digit growth... The goal of the Vyleesi program is to demonstrate commercial product value in the marketplace. With six consecutive quarters... I think we are doing that." That is a contrast? "The goal was to demonstrate; now we are doing that" with repeated quarters. But is it "recently crossed"? Six quarters of growth means crossing occurred earlier. "continued growth" not fresh crossing. Another: "We are excited that Vyleesi quarterly net product revenue continues to exceed Vyleesi quarterly operating expenses, i.e., we make some money." This may indicate now profitable product, but no before/after contrast. "we have developed a co-formulation of our melanocortin receptor-4 agonist bremelanotide with a phosphodiesterase-5 inhibitor as a treatment for men with erectile dysfunction that have failed current PDE-5 inhibitor therapy." That's development, not demonstration.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ASB | Associated Banc-Corp | Q1 2024 | 2024-04-25 | A |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
DXCM · Q4 2023 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after contrast on the Malaysia manufacturing facility: previously they relied on established US facilities, but mid-year they opened a new site and are now ramping production with yields matching the US ones—real, repeated activity rather than a single event or plan. This is framed as 2023 being transformational, with the new capability already contributing to results and positioned for further scaling ahead. The primary-care expansion also fits as a demonstrated shift from long-term investment to immediate results (70% of new scripts), but the manufacturing crossing is the clearest match to the criteria.
LC · Q4 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES The transcript shows management drawing a clear before/after line: Scott Sanborn describes closing 2021 in the strongest position after executing a strategy laid out in February, creating America's first digital marketplace bank; Tom Casey states the radical transformation over the last year is now complete as promised, contrasting it with 2019 4Q revenue and net income levels to highlight the fundamental change. The after-side is real and repeated—record revenue, doubled economics, NII recurring stream, multiple quarters of strong performance—backed by actual bank operations and deliveries.
KTB · Q3 2021 → YESThe question is about whether management conveys that the company has recently crossed from claiming something to demonstrating it. YES Management draws its own before/after line in Scott Baxter’s opening remarks: “we are doing things with both the Wrangler and Lee brands that we have simply never done before,” directly contrasting past practice with the current reality of new marketing campaigns (Lee launched October, Wrangler September). The after-side is 1) real and recent (Q3 results show 50 % growth in U.S. outdoor and 60 % growth in work wear versus 2019 baselines) and 2) repeated across multiple categories and brands, confirming the capability is now operating rather than a one-off event.